Alexion Buys $111M Taligen Therapeutics
Alexion Pharmaceuticals has acquired Massachusetts-based biotechnology firm, Taligen Therapeutics.
February 2, 2011
Contact Info
New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300
London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888
Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001
Subscription
Subscribe to Premium
Register
Register for Free Account
Newsletters
Sign up for II newsletters
© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.
4.15.05 build:2026-02-06 Login